| # | Side effect | Count |
|---|---|---|
| 0 | CYTOKINE RELEASE SYNDROME | 1317 |
| 1 | DISEASE PROGRESSION | 494 |
| 2 | PYREXIA | 369 |
| 3 | OFF LABEL USE | 356 |
| 4 | DEATH | 342 |
| 5 | DIFFUSE LARGE B-CELL LYMPHOMA | 299 |
| 6 | IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME | 264 |
| 7 | DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY | 252 |
| 8 | NEUTROPENIA | 227 |
| 9 | COVID-19 | 180 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY | 252 | 0.2661 |
| 1 | B-CELL LYMPHOMA REFRACTORY | 12 | 0.1348 |
| 2 | FOLLICULAR LYMPHOMA REFRACTORY | 7 | 0.1077 |
| 3 | TUMOUR FLARE | 66 | 0.0966 |
| 4 | CYTOKINE RELEASE SYNDROME | 1317 | 0.0656 |
| 5 | IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME | 264 | 0.0445 |
| 6 | DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT | 97 | 0.0440 |
| 7 | DIFFUSE LARGE B-CELL LYMPHOMA | 299 | 0.0388 |
| 8 | COR PULMONALE CHRONIC | 7 | 0.0372 |
| 9 | INTERLEUKIN-2 RECEPTOR INCREASED | 6 | 0.0351 |